India lacks a dedicated early warning system for detecting and responding to emerging drug threats like NPS or synthetic ...

Scientists at Medical University of Vienna, The University of Queensland and Universität Innsbruck have identified cysteine stapled dynorphin A (CSD) analogues acting as κ-opioid receptor antagonists ...

WASHINGTON - While Eastern states such as North Carolina and Pennsylvania are seeing significant declines in opioid-related ...

In this systematic review, evidence for the efficacy of acute pain interventions on individuals with opioid use disorder was ...

Virginia Commonwealth University has synthesized nitrogen-walk derivatives of NAN acting as µ-opioid receptor modulators reported to be useful for the treatment of pain, opioid dependency and ...

Opioid use disorder is associated with more than 350,000 deaths annually worldwide. Guided by the need for an increased ...

receptor and µ-opioid peptide (MOP) receptor (dual-NMR) agonism. This dual-NMR agonist has the potential to deliver significant pain relief comparable to opioids with minimized risk of ...

Purpose. Published reports on placebo-controlled clinical trials and other studies investigating the use of pure opioid antagonists for the prevention and treatment of opioid-induced pruritus (OIP ...

Eluxadoline tablets will be produced at Zydus Lifesciences Ltd (SEZ) in Ahmedabad, the company said in an exchange filing.

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...